Breaking News

Thermo Fisher Scientific Further Expands Global Footprint

Will expand sites in Greenville, NC; Swindon, UK; and Ferentino and Monza, Italy for sterile drug product development and commercial manufacturing.

By: Contract Pharma

Contract Pharma Staff

Thermo Fisher Scientific will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines. Thermo Fisher will expand sites in Greenville, NC; Swindon, UK; and Ferentino and Monza, Italy. The investment will add 15 development and cGMP commercial production lines, as well as a range of capabilities including live virus, aseptic liquid and lyophilized vial filling. These projects are ex...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters